Back to company

VIAD PHARMA ApS: Financial statements 2017

CVR: 36433892

VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,537,937 and a net result of DKK 676,743 compared with DKK 623,135 the year before. That is an increase of 6.6% compared with the year before. Equity amounted to DKK 760,941. The solvency ratio was 68%.

Gross Profit
1,537,937 kr.
Profit/Loss
676,743 kr.
Equity
760,941 kr.
Total Assets
1,119,166 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-1.5 mio.677 t.761 t.-
2016-1.4 mio.623 t.684 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like VIAD PHARMA ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

VIAD PHARMA ApS: The 2016 annual report is outMay 26, 2017

VIAD PHARMA ApS has published its annual report for 2016. Gross profit came to DKK 1,442,424, and the net result was DKK 623,135.

About VIAD PHARMA ApS

VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity amounted to DKK 236,399.